Please login or register first to view this content.
Oncology Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi’s sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
NEWS & FEATURES
Keytruda Approved as First-Line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer
Verzenio Plus Endocrine Therapy Approved for HR+, HER2-, Early Breast Cancer
Drug Metabolism May Be Suppressed in Patients With Inflammatory Conditions
Lung Cancer Treatment May Impact Daily Function in Older Adults
Multimodel Anesthesia May Cut Opioid Usage After Head and Neck Cancer Surgery
Tecartus Approved for Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Revised Guidelines Perpetuate Disparities in Lung Cancer Screening
Taxane-Containing Chemo Associated With Persistent Alopecia
Erbitux Plus Encorafenib Approved for BRAF V600E Mutation-Positive Metastatic Colorectal Cancer
Abiraterone Acetate + Prednisone Cuts Metastasis in Prostate Cancer
Many Oral Anticancer Drugs Require Prior Authorization
RAI Therapy for Hyperthyroidism Not Tied to Overall Cancer Risk
HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
Relatlimab-Nivolumab Fixed-Dose Combo Gets Priority Review for Melanoma
Tivdak Approved for Recurrent or Metastatic Cervical Cancer
Durvalumab Plus Chemo Showed Continued Survival Benefit in Extensive-Stage SCLC
Cabometyx Approved for Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Ribociclib Improves Survival by More Than 1 Year in Advanced Breast Cancer
